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In all vertebrate species, endogenous estrogens
(E2) play a crucial role in the development,
maintenance, and function of female and male
reproductive tracts. In addition, the impor-
tance of E2 in many other tissues such as bone,
the cardiovascular system, and the central ner-
vous system is well documented (Emmen and
Korach 2003; Enmark et al. 1997; Maggi et al.
2000; McDonnell 2003). In mammals, two
estrogen receptors (ER-α and ER-β) generated
from two distinct genes have been character-
ized (Green et al. 1986; Kuiper et al. 1996).
These receptors show partially distinct expres-
sion patterns, and their activities are modu-
lated differently by some ligands called
selective ER modulators (SERMs) (Gustafsson
1998; Katzenellenbogen et al. 2000). Among
the compounds affecting ER signaling are an
increasing number of man-made substances or
natural phytoestrogens with estrogenic or anti-
estrogenic properties.
Indeed, in the 1990s, the appearance of
adverse reproductive effects in aquatic and
wildlife species living within or near contami-
nated areas was reported in scientiﬁc literature
(Colborn et al. 1993; Giesy et al. 1994;
Guillette et al. 1994; Sumpter and Jobling
1993). To determine whether environmental
contaminants could alter the function of the
endocrine systems, male wild fish in U.K.
rivers were exposed to effluents from waste-
water treatment works (Sumpter 1995;
Sumpter and Jobling 1995). Male ﬁsh in these
studies showed intersex phenomena (female
ovarian tissue within the testes) and produced
vitellogenin, a protein required for egg yolk
production in females. Moreover, in a study by
Sharpe et al. (1995), the exposure of rats to
xenoestrogens during gestation and lactation
resulted in reduced testicular size and sperm
production. In parallel, several in vitro and
cell-based assays showed that some substances
generated from pesticides, herbicides, plastic
components, heavy metals, pharmaceuticals,
and so forth, have estrogenic or antiestrogenic
activity (Balaguer et al. 1996; Flouriot et al.
1995; Petit et al. 1997; Soto et al. 1991,
1995). Together, these observations led to the
conclusion that environmental contaminants
may interfere with normal hormonal processes
and act as estrogenic or antiestrogenic chemi-
cals (Colborn et al. 1993; Sharpe and
Skakkebaek 1993; Sohoni and Sumpter 1998;
Sonnenschein and Soto 1998; Sumpter 1995).
Various ﬁsh species, particularly zebraﬁsh,
are commonly used as model organisms to ana-
lyze the impact of endocrine disruptors (EDs)
found in the environment. In ﬁsh, the existence
of three rather than two ERs (Hawkins et al.
2000; Menuet et al. 2002), characterized as
ER-α, ER-β1, and ER-β2, indicates that the
mechanism of action of estrogens and environ-
mental estrogenic chemicals may be more com-
plex than previously envisioned. We reported
previously that zebraﬁsh ERs (zfERs) are pre-
dominantly expressed in the reproductive tis-
sues and also in the brain, where the three ERs
showed partially overlapping patterns (Menuet
et al. 2002). The brain of teleost ﬁsh is charac-
terized by an important aromatase activity that
is due to the expression of a brain-speciﬁc aro-
matase gene, encoding cytochrome P450 aro-
matase B (Aro-B) (Tchoudakova et al. 2001).
Interestingly, expression of Aro-B is restricted to
radial glial cells (Forlano et al. 2001; Menuet
et al. 2003, 2005), and its expression is up-reg-
ulated by E2 (Kazeto et al. 2004; Kishida and
Callard 2001). We have recently shown in vivo
and in vitro that, in zebraﬁsh, this E2 up-regula-
tion of Aro-B expression requires the presence
of functional ERs and occurs only in glial cell
contexts (Menuet et al. 2005). Aro-B is a cru-
cial enzyme that aromatizes androgens into
estrogens, and this local production of E2 is
likely to be very important for the develop-
ment, growth, and sex differentiation of the
brain. There is also an indication that the
Aro-B gene can be used as a sensitive marker of
the effects of xenoestrogens on the central ner-
vous system during embryogenesis (Kishida
et al. 2001) and in zebraﬁsh juveniles (Kazeto
et al. 2004). However, to date, there is no
report on the potential transcriptional effects of
xenoestrogens on the Aro-B promoter due to
the lack of appropriate cell-based assays.
Recently, we linked 500 bp of the proxi-
mal promoter region of zebraﬁsh Aro-B gene
to the luciferase reporter gene. Transfection
experiments with the promoter-luciferase
reporter in different cell contexts showed
that, similar to the in vivo situation, full E2
up-regulation of the Aro-B gene is restricted
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The brain cytochrome P450 aromatase (Aro-B) in zebraﬁsh is expressed in radial glial cells and is
strongly stimulated by estrogens (E2); thus, it can be used in vivo as a biomarker of xenoestrogen
effects on the central nervous system. By quantitative real-time polymerase chain reaction, we ﬁrst
conﬁrmed that the expression of Aro-B gene is robustly stimulated in juvenile zebraﬁsh exposed to
several xenoestrogens. To investigate the impact of environmental estrogenic chemicals on distinct
estrogen receptor (ER) activity, we developed a glial cell-based assay using Aro-B as the target
gene. To this end, the ER-negative glial cell line U251-MG was transfected with the three
zebraﬁsh ER subtypes and the Aro-B promoter linked to a luciferase reporter gene. E2 treatment
of U251-MG glial cells cotransfected with zebrafish ER-α and the Aro-B promoter–luciferase
reporter resulted in a 60- to 80-fold stimulation of luciferase activity. The detection limit was
< 0.05 nM, and the EC50 (median effective concentration) was 1.4 nM. Interestingly, in this glial
cell context, maximal induction achieved with the Aro-B reporter was three times greater than that
observed with a classical estrogen-response-element reporter gene (ERE-tk-Luc). Dose–response
analyses with ethynylestradiol (EE2), estrone (E1), α-zeralenol, and genistein showed that estro-
genic potency of these agents markedly differed depending on the ER subtype in the assay.
Moreover, the combination of these agents showed an additive effect according to the concept of
concentration addition. This confirmed that the combined additive effect of the xenoestrogens
leads to an enhancement of the estrogenic potency, even when each single agent might be present
at low effect concentrations. In conclusion, we demonstrate that our bioassay provides a fast, reli-
able, sensitive, and efﬁcient test for evaluating estrogenic potency of endocrine disruptors on ER
subtypes in a glial context. Key words: aromatase gene, brain, endocrine disruptors, estrogen recep-
tors, glial cells, xenoestrogens, zebrafish. Environ Health Perspect 114:752–758 (2006).
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line U251-MG (Menuet et al. 2005).
In this study, we tested the impact of sev-
eral xenoestrogens, individually or in mixture,
on the transcriptional activity of three distinct
ERs in this glial cell context. To achieve this,
we used the ER-negative glial cell line
U251-MG to express each ER subtype and the
endogenous zebraﬁsh Aro-B promoter as the
reporter gene. We tested low-dose and mixtures
of EE2, E1, α-zeralenol, and genistein together
with E2 (positive control) and ethanol (solvent,
negative control). We chose these chemicals
because they previously have been characterized
as potent and environmentally relevant xeno-
estrogens (Kazeto et al. 2004; Le Guevel and
Pakdel 2001; Thorpe et al. 2003). Indeed,
about 80% of estrogenic activity in the U.K.
domestic efﬂuent corresponded to natural and
synthetic estrogens, such as E2, E1, and EE2
(Rodgers-Gray et al. 2001; Thorpe et al. 2003).
Our results show that all these chemicals stimu-
late Aro-B gene expression in vivo. Moreover, in
the glial cell system, all three zfERs strongly
activate the Aro-B promoter. ER-α was 2- to
3-fold more efficient than ER-β2 and 3- to
5-fold more efﬁcient than ER-β1. Although the
xenoestrogens tested did not change ER efﬁ-
ciency in activating the Aro-B reporter gene, we
found that EE2 and genistein are more sensitive
to ER-β subtypes than to ER-α. Dose–response
curves with the mixture of five estrogenic
chemicals showed that combination of these
agents results in a concentration-additive effect
in our reconstituted glial model.
Materials and Methods
In vitro transcription/translation of zfERs.
To synthesize zfER proteins, we performed an
in vitro translation reaction using 1 µg of each
ER expression vector and T7 RNA poly-
merase in a rabbit reticulocyte lysate. The
reaction was performed in the presence of
35S-methionine at 30°C for 90 min as recom-
mended by the supplier (Quick TNT;
Promega, Madison, WI, USA).
Cell culture and transfection. U251-MG
cells were maintained at 37°C in 5% CO2
atmosphere in phenol red–free Dulbecco's
Modified Eagle’s Medium (DMEM-F12;
Sigma-Aldrich, St. Louis, MO, USA) supple-
mented with 8% fetal calf serum (FCS; Life
Technologies, Carlsbad, CA, USA). The
medium is also supplemented with 2 mM
L-glutamine (Gibco, Carlsbad, CA, USA),
20 U/mL penicillin, 20 µg/mL streptomycin,
and 50 ng/mL amphotericin B (Gibco). For
transfection experiments, cells were plated in
24-well plates at a density of 0.2 × 105
cells/mL. In each well, 25 ng of expression
vector, 25 ng of cytomegalovirus–β-galactosi-
dase control plasmid and 150 ng of luciferase
reporter construct were transfected with
FuGENE 6 transfection reagent (Roche,
Basel, Switzerland). After one night, medium
was replaced with fresh DMEM-F12 contain-
ing 2% charcoal/dextran FCS with xeno-
estrogen or vehicle. The luciferase activities
were assayed 48 hr later using the luciferase
assay system (Promega). We used β-galactosi-
dase activity to normalize transfection effi-
ciency in all experiments. Each experiment was
performed at least in triplicate.
Plasmid construction and site-direct
mutagenesis. The zfER-α, zfER-β1, and
zfER-β2 expression vectors correspond to
Topo-pcDNA3 expression vector (Invitrogen,
San Diego, CA, USA), containing the coding
regions of each receptor cDNA as previously
described (Menuet et al. 2002). The estrogen
response element (ERE)–thymidine kinase–
luciferase reporter gene (ERE-tk-Luc) consists
of a consensus ERE with a minimal thymidine
kinase promoter driving ﬁreﬂy luciferase activ-
ity. This well-characterized ERE reporter
responds to all ER subtypes in several cell lines
(Ackermann et al. 2002; Menuet et al. 2002,
2005; Metivier et al. 2001).
The Aro-B reporter gene consists of 500 bp
of the proximal promoter region of zebraﬁsh
cytochrome P450 19b gene, containing an
ERE, coupled to the luciferase reporter gene.
This reporter gene was described previously by
Menuet et al. (2005).
The Aro-B mutated reporter construct
(Aro-B mut) is similar to the Aro-B reporter
wild type except that the ERE was mutated
by site-directed mutagenesis. We used the
QuickChange site-directed mutagenesis kit
from Stratagene (La Jolla, CA, USA) and the
following primers: 5´-GGTTCTGAATCA-
GTCTGAAATGCCTTCATTAAAAGC-3´
and 5´-AATGAAGGCATTTCAGACTGAT-
TCAGAACCAAACC-3´. Each construct was
sequenced by the PRISM (Perkin Elmer
Applied Biosystems, Foster City, CA, USA)
ready reaction big dye terminator cycle
sequencing protocol. 
Zebrafish exposure to xenoestrogens and
RNA extraction. All zebraﬁsh were from our
local facility. They are raised in 28.5°C recircu-
lated water and kept under a 12-hr dark/12-hr
light cycle. Animals were treated in agreement
with the European Union regulations concern-
ing the protection of experimental animals. At
least 10 juvenile zebraﬁsh 18–21 days of age
were exposed to xenoestrogens or vehicle for
3 days in glass tanks containing 100 mL
embryo medium (15 mM NaCl, 0.5 mM KCl,
1 mM MgSO4, 1 mM CaCl2, 0.15 mM
KH2PO4, 0.05 mM Na2HPO4, 0.7 mM
NaHCO3, 10–5% methylene blue; pH 7.5).
The medium was maintained at 26°C and
replaced every day. After exposure, 10 zebraﬁsh
were sonicated together (10 sec, three times) in
1 mL Trizol Reagent (Gibco), and total RNA
was extracted according to the manufacturer’s
protocol.
Quantitative real-time PCR. Reverse
transcription was carried out by incubating
2 µg total RNA with 5 mM random hexamer
oligonucleotides, 10 mM DTT, 2.5 mM
dNTPs and 100 U MMLV-RT (Promega) in
the appropriate buffer for 30 min at 37°C
and 15 min at 42°C. Polymerase chain reac-
tion (PCR) reactions were performed in an
iCycler thermocycler coupled to the MyiQ
detector (Bio-Rad. Hercules, CA, USA) using
iQ SYBR-Green Supermix (Bio-Rad) accord-
ing to the manufacturer’s protocol. The fol-
lowing primers were used: Aro-B reverse
transcriptase (RT)-up 5´-TCGGCACG-
GCGTGCAACTAC-3´, Aro-B RT-down 5´-
CATACCTATGCATTGCAGACC-3´,
GAPDH-up 5´-GAGCACCAGGTTGT-
GTCCA-3´, GAPDH-down 5´-TGTCAT-
ACCATGTGACCAGCTT-3´. Expression
levels of GAPDH mRNA were used to nor-
malize the expression levels of Aro-B mRNA.
Melting curve and PCR efficiency analyses
were performed to conﬁrm a correct ampliﬁ-
cation. Each experiment was performed at
least twice in triplicate.
Concentration effect analyses. We deter-
mined concentration–response relationships
for the single compounds and for the mix-
tures using the best-ﬁt approach described by
Scholze et al. (2001). We used this informa-
tion to calculate predicted mixture effects,
with a ratio proportional to equieffective
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Figure 1. Environmental estrogenic chemicals stimulate the expression of Aro-B in zebraﬁsh juveniles. At
least 10 juvenile zebraﬁsh 18–21 days of age were exposed to ethanol solvent (EtOH), 10 nM E2, 1 nM EE2,
100 nM E1, 100 nM α-zeralenol, or 1 µM genistein. (A) Expression of Aro-B measured in triplicate by real-
time quantitative RT-PCR of total RNA prepared from pooled animals. Fold induction was expressed rela-
tive to the solvent; data are presented as mean ± SE of two separate exposures. (B) DNA fragment
ampliﬁed by PCR for Aro-B and GAPDH (internal control) migrated at the expected sizes on the agarose
gel, stained by ethidium bromide. Le Page et al.
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concentrations producing an effect of 30% for
ER-α expression. The concept of concentra-
tion addition was used; for a detailed descrip-
tion, see Rajapakse et al. (2004). The statistical
uncertainties for the predicted mean effect
were expressed as 95% confidence belt and
determined by using the bootstrap method
(Efron and Tibshirani 1993).
Results
Aro-B is a highly sensitive biomarker of
xenoestrogens in vivo. We tested the ability of
individual chemicals to stimulate the expres-
sion of zebrafish brain Aro-B in vivo.
Zebrafish juveniles, 18–21 days of age, were
exposed for 3 days to E2 (10 nM), EE2
(1 nM), E1 (100 nM), α-zeralenol (100 nM),
and genistein (1 µM), according to the rela-
tive estrogenicity of those chemicals. For each
treatment, we used a pool of 10 juveniles, and
we prepared total RNA from whole bodies.
Figure 1 shows the expression of Aro-B meas-
ured by real-time quantitative RT-PCR
experiments. As we expected, E2, EE2, E1,
and α-zeralenol robustly stimulated the
expression of Aro-B, whereas the expression
of GAPDH—used as an internal control—
remained unchanged. In these experiments, the
fold stimulation of the Aro-B gene by xeno-
estrogens was about six to eight times that of
the solvent control. Surprisingly, genistein is
less potent than other chemicals, although we
used a relatively high concentration (Figure 1).
Estrogenic responsiveness of the reconsti-
tuted glial cell model. The ER-negative glial
cell line U251-MG was transfected with
zfER-α expression vector together with the
ERE-tk-Luc reporter gene, the Aro-B reporter
gene, or the Aro-B mut reporter gene. The sen-
sitivity of the assay was tested with 0.1 and
10 nM E2 for 48 hr in 24-well plates
(Figure 2). Relative to the cell controls (with-
out ER expression vector), 10 nM E2 increased
luciferase activity 22-fold from the ERE-tk-Luc
reporter gene, whereas it increased luciferase
activity 65-fold from the Aro-B reporter gene.
As demonstrated by the Aro-B mut gene, the
estrogenic effect of E2 required the integrity of
the ERE sequence within the Aro-B promoter.
Indeed, site-directed mutagenesis of this ERE
completely abolished E2 stimulation of the
Aro-B reporter gene.
Figure 3A shows that all three receptors
were correctly expressed in vitro with a molec-
ular mass of approximately 65 kDa in the rab-
bit reticulocyte lysate system.
To test whether receptor concentration
could affect E2 stimulation of the Aro-B
reporter gene differently in U251-MG cells,
increasing amounts of zfER expression vectors
were tested. Figure 3B shows that E2 stimula-
tion of luciferase activity mediated by each ER
corresponds to a distinct proﬁle depending on
zfER subtype. These proﬁles were not modiﬁed
when receptor concentration was increased.
Dose–response analysis of individual
chemicals in the reconstituted glial cell model.
The glial cell line U251-MG was transfected
with each zfER subtype (ER-α, ER-β1, and
ER-β2) expression vector together with Aro-B
wild-type reporter gene. Cells were treated
with E2, EE2, E1, genistein, and α-zeralenol
(Figure 4). We tested seven concentrations of
each chemical, ranging from picomolar to
micromolar. Estrogenic activity of each chemi-
cal was analyzed by the three ER subtypes and
is represented as fold induction of luciferase
activity versus control (luciferase reporter gene
without ER). In all cases, ER-α stimulated 60-
to 80-fold luciferase activity, whereas the
maximum stimulation of the Aro-B reporter
gene by ER-β1 and ER-β2 was two to six
times lower (Figure 4, Table 1). ER-β2 stimu-
lated 20- to 40-fold luciferase activity, whereas
ER-β1 stimulated Aro-B reporter gene 10- to
20-fold. Table 1 shows the EC50 (median
effective concentration) of different chemicals
calculated for each ER subtype from the dose–
response curves. Interestingly, the EC50 values
of EE2 and genistein were lower for ER-β2
than those calculated for ER-α. In contrast,
the EC50 of E1 was lower for ER-α than for
ER-β2. Table 1 also shows the detection limit,
arbitrarily ﬁxed at 2-fold the basal activity and
maximum induction for each chemical.
Even at the highest concentration of all
chemicals, we found no luciferase activity with-
out cotransfected ER-α or ER-β expression
plasmids, conﬁrming that the transcriptional
activity was mediated by ER protein (data not
shown). Similarly, we found no luciferase
activity with any of the chemicals using the
mutated Aro-B reporter gene (Figure 5). This
clearly indicated that stimulation of luciferase
by these chemicals requires direct interaction
between ER and the Aro-B reporter gene.
Combination effect of xenoestrogens in the
reconstituted glial cell model. To investigate
the mixture effect of E2, EE2, E1, α-zeralenol,
and genistein, we determined the ratio for each
chemical that should be present in the mixture
at an equal potency on the basis of the individ-
ual dose–response curves (Kortenkamp and
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Figure 2. Aro-B reporter gene up-regulation by E2 in the glial cell line U251-MG. (A) Schematic representation of the three luciferase reporter constructs used
(see “Materials and Methods” for description). (B) Fold induction in U251-MG cells transfected with empty expression vector (control) or zfER-α expression vec-
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Figure 3. Examination of receptor concentration on E2 stimulation of Aro-B reporter gene. (A) zfERs produced
as 35S-methionine–labeled proteins in a rabbit reticulocyte lysate and visualized by autoradiography after
SDS-PAGE. (B) Dose effect of ERs in U251-MG cells transfected with the Aro-B reporter gene and increasing
amounts of zfER expression vectors. Cells were treated with or without E2 (10–8 M) for 48 hr before luciferase
activity was measured. Data are expressed as fold induction relative to empty vector (control). Altenburger 1999; Silva et al. 2002), here at
concentrations producing an effect of 30% for
ER-α expression. The advantage of this equi-
effective design is that all components con-
tributed nearly equally to the overall mixture
effect, at least for the ER-α expression and, of
course, when the concept of concentration
addition holds true. On the other hand, rele-
vant nonchemical interactions may have the
chance to become visible and are not masked
by the presence of a dominant compound.
We tested the relative potency of this mix-
ture at different concentrations ranging from
1 to 100 nM. A signiﬁcant high stimulation of
luciferase activity was found when the glial cells
were treated with increasing concentration of a
mixture of the ﬁve chemicals, whereas each of
those chemicals, at the concentration present
in the mixture, is expected to produce only a
weak effect if tested singly. As shown in
Figure 6, the combination of the ﬁve chemicals
tested experimentally with ER-α, ER-β1, and
ER-β2 showed an additive effect as predicted
by the concept of concentration (Rajapakse
et al. 2002). However, for ER-β1 and ER-β2
the effect ranges for the predictions are limited:
mixture effects can be determined by the con-
centration addition model only when it is pos-
sible to determine for each mixture compound
a reliable estimate of a concentration that
would produce the same effect when applied
on its own. Figure 4 shows that the curve esti-
mates for maximal effects of all tested chemi-
cals differ, for example, with α-zeralenol
producing the lowest maximal effect (10%) rel-
ative to the controls for ER-β1. Thus, concen-
trations of α-zeralenol yielding effects > 10%
cannot be estimated for this end point, and
mixture concentrations corresponding to
effects > 10% were impossible to calculate.
Thus, Figure 6 demonstrates clearly that the
mixture may induce a response that is higher
than is possible to induce by one of the com-
pounds. The mixture induced a maximum
response of the reporter gene that was about
50-fold with ER-α, whereas each of the chemi-
cals, at a concentration present in the mixture,
induced the reporter gene only 8- to 15-fold
(Figure 6D).
Discussion
A current issue for regulatory agencies is to
evaluate the potential endocrine-disrupting
effects of thousands of chemicals. In particular,
estrogenic potency of many environmental
persistent chemicals is an important concern
for these agencies. At the international level,
the consensus recommendation for the assess-
ment of such chemicals is a tiered series of
in vivo and in vitro protocols. With in vivo
assays, such as rodent uterotrophic assays, vitel-
logenin assays, or somatic gene transfer into
the brain of adult ﬁsh (Trudeau et al. 2005),
chemicals may be metabolized and may act dif-
ferently compared with their parental chemi-
cals. However, in vivo assays are not suited for
the large-scale screening of chemicals because
of their cost and complexity and also because
these bioassays require the sacrifice of many
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Figure 4. Dose-dependent effect of E2 and xenoestrogens on the transcriptional activation of zfERs in U251-MG cells transfected with the Aro-B reporter gene and
the zfER expression vectors. Cells were treated with increasing concentrations of (A) E2 (10–11 M to 10–7 M), (B)E E 2 (10–12 M to 10–8 M), (C)E 1 (10–11 M to 10–7 M),
(D) genistein (10–9 M to 10–5 M), or (E) α-zeralenol (10–12 M to 10–8 M). Data are expressed as fold induction relative to empty vector (control) from at least three
experiments. 
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lanimals. Moreover, these bioassays are limited
for analyzing the molecular mechanisms of
action of environmental chemicals. For exam-
ple, a compound that is a selective ER-β ago-
nist/antagonist would not be expected to show
positive effect in tissues that do not express this
ER subtype. On the other hand, in vitro assays
such as ours would be able to identify this com-
pound. Thus, cell-based reporter gene assays are
useful means for evaluating the impact of envi-
ronmental contaminants on the cellular signal-
ing pathways and cellular responses. We and
others have developed several in vitro bioassays
based on mammary, endometrial, hepatic, and
yeast models for the characterization of envi-
ronmental estrogenic chemicals (Ackermann
et al. 2002; Andersen et al. 1999; Balaguer et al.
1999; Legler et al. 1999; Le Guevel and Pakdel
2001; Petit et al. 1997; Routledge and Sumpter
1997; Soto et al. 1995).
In this article, we report the development
and validation of a new glial cell-based assay
providing a fast, reliable, sensitive, and highly
responsive test for evaluating the estrogenic or
antiestrogenic potency of EDs. We ﬁrst con-
firmed that Aro-B is a suitable biomarker to
detect the estrogenic potency of chemicals.
Indeed, E2, EE2, E1, and α-zeralenol strongly
stimulated Aro-B gene expression in vivo. How-
ever, genistein, a well-known phytoestrogen,
showed very poor activity. Different reasons
could explain this observation, such as stability,
transport, and bioavailability. Another explana-
tion, highlighted by our in vitro experiments,
could be that genistein is more potent for
ER-β transcriptional activity. In that case,
induction of Aro-B might be weak if only
ER-α is present in the radial glial cells at this
time of zebrafish development or if the
ER-α:ER-β ratio is unfavorable. Together,
these results show the limitation of such in vivo
tests that might be overcome by using addi-
tional in vitro approaches.
One of the advantages of this new cell-
based system is that it uses an ER-negative
glial cell line. Thus, estrogenic potency of the
chemicals can be analyzed on the transcrip-
tional activity of distinct ER subtypes or of a
combination of ERs if necessary. Another
advantage of this test is that it is based on the
use of an endogenous promoter that responds
with high efficiency to natural and synthetic
estrogens in a glial cell context. A limitation of
this assay is that, given the lack of ﬁsh glial cell
lines, it is based on a heterologous cell context.
Nevertheless, we believe that it reﬂects the in
vivo situation in ﬁsh because Aro-B is up-regu-
lated by E2 only in radial glial cells in vivo.
Interestingly, the endogenous Aro-B reporter
construct was 3-fold more efficient than the
classical ERE-tk-Luc reporter construct com-
monly used for the screening of estrogenic
chemicals. These results suggest that ER may
recruit glial-specific factor(s) to mediate E2
stimulation of the Aro-B reporter construct.
However, all the three ERs did not show simi-
lar activity on this reporter gene. In fact, using
ﬁve potent and structurally different estrogens
or xenoestrogens, we found that the highest
luciferase activity was achieved with ER-α.
The luciferase activity was about 2--fold lower
with ER-β2, whereas the luciferase activity was
4- to 6-fold lower with ER-β1.
The mammalian ER-β showed also lower
transcriptional activity compared with ER-α in
transient transfection experiments using differ-
ent cell lines and reporter gene constructs
(Loven et al. 2001). The reason for that is cur-
rently unknown, but it might be due to a dif-
ferential degradation rate of receptor proteins
or a differential stability of the receptor–DNA
or receptor–ligand complexes. It might also
reﬂect a differential expression of ER-speciﬁc
cofactors. Nevertheless, it is interesting to note
that, without any ligand, zfER-α consistently
stimulated the luciferase activity by 2-fold.
This relatively low but signiﬁcant ligand-inde-
pendent activity was not observed for ER-β1
and ER-β2. Thus, this glial cell system with
ER-β2 showed a detection limit two to five
times lower than that for glial cells containing
ER-α. At present, it is not clear why ER-α
showed a ligand-independent activity in this
glial cell context. One reason may be the struc-
tural differences in the N-terminal A/B region
of zfER-α compared with that of zfER-β sub-
types (Menuet et al. 2002). Indeed, this region
that was very well characterized as responsible
for the ligand-independent activity [ER-α
transactivation function 1 (AF-1)] of ERs
(Metivier et al. 2000, 2001) and can be regu-
lated by cell-speciﬁc factors. The activity of ER
AF-1 varies depending upon the target gene
and cell type (Merot et al. 2004; Tora et al.
1989; Tzukerman et al. 1994). Additionally, in
some cases the activity of AF-1 can be stimu-
lated by phosphorylation in response to growth
factors (Kato et al. 1995). The phosphoryla-
tion residues may therefore differ among
Le Page et al.
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Table 1. Potency of different compounds tested in the glial cell system.
Compound, Maximum
ratio in mixa Receptor EC50 (M)b RSA (%)c RS/ER-αd inductione LOEC (pM)f
E2, 0.007 ER-α 1.4 × 10–9 27 1.0 70 50–100
ER-β1 1.9 × 10–10 19 7.4 12 10–50
ER-β2 7.4 × 10–10 10 1.9 34 10–50
EE2, 0.003 ER-α 3.8 × 10–10 100 1.0 56 10–50
ER-β1 3.7 × 10–11 100 10.3 22 1–10
ER-β2 7.2 × 10–11 100 5.3 35 1–10
E1, 0.035 ER-α 4.1 × 10–9 9 1.0 86 100–500
ER-β1 7.2 × 10–9 0.5 0.6 18 100–500
ER-β2 2.9 × 10–8 0.3 0.1 46 100–500
Genistein, 0.950 ER-α 2.0 × 10–7 0.2 1.0 71 5,000–10,000
ER-β1 5.3 × 10–7 0.01 0.4 25 5,000–10,000
ER-β2 2.9 × 10–8 0.2 6.9 25 500–1,000
α-Zeralenol, 0.005 ER-α 5.9 × 10–10 64 1.0 79 10–50
ER-β1 1.1 × 10–10 34 5.4 17 10–50
ER-β2 1.5 × 10–10 48 3.9 23 100–500
Abbreviations: LOEC, least observable effect concentration; RS, relative sensitivity; RSA, relative stimulatory activity. All
values were determined from data shown in Figures 4 and 6. 
aProportion of each compound in the mixture experiment presented in Figure 6. bBased on luciferase activity. cDetermined
as percentage of estrogenic effect relative to EE2. dComparison of ER-α, ER-β1, and ER-β2 for different compounds; in all
cases, the response with ER-α was arbitrarily set at 1. eMaximum fold induction of the reporter gene relative to the reporter
gene without ERs and compounds. fThe lowest concentration for which 2-fold induction of the reporter gene was obtained. 
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Figure 5. Activation of the Aro-B reporter gene by xenoestrogens in U251-MG cells transfected with Aro-B wild-type or Aro-B mut reporter genes and expression
vectors. (A) zfER-α. (B) zfER-β1. (C) zfER-β2. Cells were treated with 0.1% ethanol (EtOH), E2, EE2, E1, genistein, α-zeralenol, or a mixture. Data are expressed as the
percentage of induction relative to E2 from at least three independent experiments; control represents luciferase activity obtained with empty expression vector. ER-α, ER-β1, and ER-β2. Alternatively, ER-α
may be more sensitive than ER-β subtypes to
alkylphenols that could be released from
plasticware (Soto et al. 1991).
Although the maximum responses with
ER-β were weaker than those with ER-α, the
EC50 values indicate that ER-βs can be more
sensitive to some xenoestrogens compared with
ER-α. For instance, ER-β2 was 5-fold more
sensitive to EE2 and 7-fold more sensitive to
genistein, compared with ER-α. Interestingly,
the phytoestrogen genistein also showed higher
binding afﬁnity to the human ER-β, and hence
genistein was designed as a SERM (Kuiper
et al. 1998). Although this was not our primary
objective, the glial cell model described here can
also be used for studies examining the activity
of SERMs. Of particular interest is the fact that
human ER-α can also be used in this system
(data not shown). A study with human ER-α
and ER-β showed that genistein, for example,
has an ER-β-selective afﬁnity and potency but
an ER-α-selective efﬁcacy (Barkhem et al. 1998;
Kuiper et al. 1998). In addition, tamoxifen and
raloxifene have an ER-α-selective partial ago-
nist/antagonist function but a pure antagonist
effect through ER-β (Barkhem et al. 1998;
Kuiper et al. 1998). Moreover, the agonistic or
antagonistic effect of these agents depends on
tissue and target–gene contexts (Gustafsson
1998). ER-α and ER-β are able to recruit co-
activators (TIF2 and SRC-1a) in the presence
of estrogens and some xenoestrogens in vitro
(Routledge et al. 2000). However, although
ER-α and ER-β showed relatively similar bind-
ing afﬁnities for the coactivators, the two recep-
tors differed in their ability to recruit the
coactivators after xenoestrogen binding.
The presence of low concentrations of
estrogenic chemicals in the environment led to
the question of whether exposure to weak envi-
ronmental estrogens can effectively produce
adverse hormonal effects in animals and
humans (Feldman 1997; Juberg 2000; Safe
1995). In fact, some pesticides as well as
alkylphenols, polychlorinated biphenyls, and
plastic components act with 100- to 5,000-fold
lower potency than E2 (Le Guevel and Pakdel
2001; Petit et al. 1997). However, different
parameters should be considered: ﬁrst, relative
afﬁnity and effectiveness of xenoestrogens may
differ for ER subtypes; second, xenoestrogens
may induce different responses depending on
cell and promoter context; and third, weakly
estrogenic chemicals may act as mixtures in the
environment and diet. Using a recombinant
yeast model and breast cell lines, Kortenkamp
and colleagues (Payne et al. 2000; Rajapakse
et al. 2002, 2004; Silva et al. 2002) showed
that combining xenoestrogens at levels below
individual statistically nonsigniﬁcant concen-
trations may enhance estrogenic effects. These
researchers demonstrated that the model of
concentration addition is a suitable tool for
predicting the mixture effect from the individ-
ual activity of each chemical. This model was
also conﬁrmed by an in vivo study with rain-
bow trout exposed to binary mixtures of xeno-
estrogens (Thorpe et al. 2003). In that study,
the authors showed that a binary mixture of E2
and EE2 is more potent than either of the indi-
vidual chemicals. These data therefore indicate
that, for the risk assessment, we should con-
sider the effect of the total estrogenic load of
environmental estrogens rather than the indi-
vidual effect of each chemical. In the present
study, we also show that the mixture of five
estrogenic chemicals acts in an additive manner
in a glial cell model and that the additive
action occurs with all three ERs.
In conclusion, because of the complexity
of estrogenic signaling pathways, xeno-
estrogens can act with different mechanisms of
action at different levels of organisms. To
understand and to evaluate their impact in
molecular and cellular aspects of endocrine
disruption, it is necessary to develop cell-based
transcription assay systems that could reflect
different cellular contexts. The assay described
here, in addition to being a powerful screening
tool, underscores the high sensitivity of the
Aro-B gene to EDs in a glial cell context.
Considering the role of aromatase in brain and
sex differentiation of nonmammalian species
(Fenske and Segner 2004, Pellegrini et al.
2005), adverse effects could be expected when
ﬁsh are exposed to EDs during development.
Moreover, there is increasing evidence that
glial cells are targets of estrogens. However,
very little effort has been made to investigate
the impact of environmental estrogenic
chemicals in glial cells. Here we describe a glial
cell model that enables analysis of the impact
of environmental estrogenic chemicals on
transcriptional activity of all three ER subtypes
characterized to date in a vertebrate species.
The amount of persistent chemicals has
increased over the last 20 years, which high-
lights the need for high-throughput screening
methods. In this glial cell model, the strong E2
Evaluating xenoestrogens in glial cells
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Figure 6. The effect of mixtures of xenoestrogens (E2, EE2, E1, genistein, and α-zeralenol) on the transcrip-
tional activation of zfERs in U251-MG cells transfected with the Aro-B reporter gene and expression vectors.
(A) zfER-α. (B) zfER-β1. (C) zfER-β2. (D) Effects produced with zfER-α by individual components at the con-
centrations present in the mixture, and the predicted mixture effect calculated according to the concept of
concentration addition and the observed mixture effect (treated samples). Le Page et al.
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stimulation of luciferase activity under the
control of the E2-sensitive Aro-B reporter con-
struct enables accurate results in 96-well
plates, making the assay suitable for sensitive
and reliable high-throughput screening.
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